Breaking News Instant updates and real-time market news.

NRG

NRG Energy

$42.50

-0.855 (-1.97%)

07:46
03/25/19
03/25
07:46
03/25/19
07:46

NRG Energy resumed with an Equal Weight at Morgan Stanley

Morgan Stanley analyst Stephen Byrd resumed coverage of NRG Energy with an Equal Weight rating and $64 price target, stating that he sees upside to power prices given what he views as the very tight supply-demand balance in the Texas power market. Aside from Texas upside, NRG also offers the "underappreciated positives" of resilient retail margins, an improving balance sheet, and favorable cash flow compared to other commodity-exposed industries, Byrd tells investors. However, he thinks NRG's strong and stable free cash flow outlook is already largely reflected in the stock.

  • 25

    Apr

NRG NRG Energy
$42.50

-0.855 (-1.97%)

08/06/18
SBSH
08/06/18
UPGRADE
SBSH
Buy
NRG Energy upgraded to Buy from Neutral at Citi
08/06/18
SBSH
08/06/18
UPGRADE
Target $38
SBSH
Buy
Citi brings NRG Energy back to Buy a week after downgrade
Citi analyst Praful Mehta upgraded NRG Energy to Buy from Neutral and raised his price target for the shares to $38 from $33. The analyst downgraded the shares to Neutral on July 30. In a research note partially titled "We Were Wrong. Story Stronger," Mehta says the strength of NRG's model was shown in last week's Q2 report. The analyst boosted his 2019 EBITDA estimate by $300M and 2020 estimate by $150M. He views his sum-of-the-parts valuation of $38 per share as conservative since it includes no value for buybacks or return on excess cash. NRG's "strong execution and ERCOT tightness" drives the upgrade back to Buy, Mehta tells investors in a research note.
12/10/18
SBSH
12/10/18
NO CHANGE
Target $47
SBSH
Buy
NRG Energy price target raised to $47 from $38 at Citi
Citi analyst Praful Mehta raised his price target for NRG Energy to $47 after updating his model for Q3 financials, latest management guidance, and forward commodity curves. The analyst keeps a Buy rating on the shares and remains bullish on NRG's fundamentals.
01/28/19
DBAB
01/28/19
DOWNGRADE
DBAB
Hold
NRG Energy downgraded to Hold from Buy at Deutsche Bank

TODAY'S FREE FLY STORIES

ONCS

OncoSec

$2.39

-0.04 (-1.65%)

, MRK

Merck

$88.95

0.6 (0.68%)

08:34
12/13/19
12/13
08:34
12/13/19
08:34
Hot Stocks
OncoSec reports interim results from KEYNOTE-890 study »

OncoSec announced interim…

ONCS

OncoSec

$2.39

-0.04 (-1.65%)

MRK

Merck

$88.95

0.6 (0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 24

    Jan

  • 24

    Jan

  • 05

    Feb

  • 14

    Mar

CFX

Colfax

$35.74

0.6 (1.71%)

08:34
12/13/19
12/13
08:34
12/13/19
08:34
Conference/Events
Colfax to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

SRPT

Sarepta

$100.39

-1.15 (-1.13%)

08:33
12/13/19
12/13
08:33
12/13/19
08:33
Hot Stocks
Sarepta announces $250M of non-dilutive senior secured loan financing »

Sarepta Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$305.76

2.01 (0.66%)

08:33
12/13/19
12/13
08:33
12/13/19
08:33
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

ATNX

Athenex

$16.94

-0.36 (-2.08%)

08:32
12/13/19
12/13
08:32
12/13/19
08:32
Hot Stocks
Athenex announces results from Phase III trial of oral paclitaxel »

Athenex announced results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

PFE

Pfizer

$38.54

0.3 (0.78%)

08:32
12/13/19
12/13
08:32
12/13/19
08:32
Hot Stocks
Pfizer announces CHMP recommendation for approval of Vyndaqel »

Pfizer announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TREE

LendingTree

$293.67

-13 (-4.24%)

08:31
12/13/19
12/13
08:31
12/13/19
08:31
Recommendations
LendingTree analyst commentary  »

LendingTree price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNM

Unum Group

$31.01

0.82 (2.72%)

08:30
12/13/19
12/13
08:30
12/13/19
08:30
Conference/Events
Unum Group to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

08:30
12/13/19
12/13
08:30
12/13/19
08:30
Options
One option delisting on December 13th »

Option delistings…

08:25
12/13/19
12/13
08:25
12/13/19
08:25
Conference/Events
Federal Reserve Bank of New York president participates in a discussion »

New York Federal Reserve…

FORM

FormFactor

$24.96

1.19 (5.01%)

, INTC

Intel

$57.56

0.52 (0.91%)

08:25
12/13/19
12/13
08:25
12/13/19
08:25
Recommendations
FormFactor, Intel, Samsung, TSMC analyst commentary  »

FormFactor price target…

FORM

FormFactor

$24.96

1.19 (5.01%)

INTC

Intel

$57.56

0.52 (0.91%)

SSNLF

Samsung

$0.00

(0.00%)

TSM

TSMC

$58.61

2.71 (4.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 23

    Jan

$DJT

DJ Transportation Average

$0.00

(0.00%)

08:24
12/13/19
12/13
08:24
12/13/19
08:24
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJU

DJ Utility Average

$0.00

(0.00%)

08:24
12/13/19
12/13
08:24
12/13/19
08:24
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

08:24
12/13/19
12/13
08:24
12/13/19
08:24
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAS

Masco

$47.44

1 (2.15%)

, FBHS

Fortune Brands

$65.51

0.31 (0.48%)

08:24
12/13/19
12/13
08:24
12/13/19
08:24
Recommendations
Masco, Fortune Brands analyst commentary  »

Masco, Fortune Brands…

MAS

Masco

$47.44

1 (2.15%)

FBHS

Fortune Brands

$65.51

0.31 (0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYT

iShares Transportation Average

$194.19

2.09 (1.09%)

08:24
12/13/19
12/13
08:24
12/13/19
08:24
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLK

Technology Select Sector SPDR

$88.89

0.9 (1.02%)

08:23
12/13/19
12/13
08:23
12/13/19
08:23
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$60.86

1.19 (1.99%)

08:23
12/13/19
12/13
08:23
12/13/19
08:23
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HZNP

Horizon Pharma

$32.84

0.58 (1.80%)

08:23
12/13/19
12/13
08:23
12/13/19
08:23
Conference/Events
The FDA Dermatologic & Ophthalmic Drugs Advisory Committee to hold a meeting »

The Committee discusses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 08

    Mar

XLY

Consumer Discretionary Sector SPDR

$123.10

1.12 (0.92%)

08:23
12/13/19
12/13
08:23
12/13/19
08:23
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLB

S&P Select Materials SPDR

$60.92

0.85 (1.42%)

08:23
12/13/19
12/13
08:23
12/13/19
08:23
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$62.86

-0.32 (-0.51%)

08:22
12/13/19
12/13
08:22
12/13/19
08:22
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLP

Consumer Staples Sector SPDR

$62.54

-0.09 (-0.14%)

08:22
12/13/19
12/13
08:22
12/13/19
08:22
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLV

Health Care Select Sector SPDR

$100.94

0.93 (0.93%)

08:22
12/13/19
12/13
08:22
12/13/19
08:22
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$163.97

1.4 (0.86%)

08:22
12/13/19
12/13
08:22
12/13/19
08:22
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.